Xbrane Biopharma AB (publ) (XBRANE)

Market
Stockholm
Sector
Healthcare
Trend
Neutral
Last close
9.76 (-2.4% on the day)
MA50
10.11
MA200
9.61
52-week range
5.66–34.65
Market cap
201.1M SEK
Dividend yield
0%
Data as of
2026-09-04
Quarterly revenue and earnings, millions of SEK
QuarterRevenueYoY %EarningsYoY %
Q1 202593.28.2
Q2 202539.9169.6
Q4 20259.1-26.5
Q1 202617.3-81.4%-13.1-260.1%
Q2 202646.817.1%-11.4-106.7%

All markets — KeepWinning global stock screener

Other companies on Stockholm: Neovici Holding AB (publ) (NEO B), Lyckegård Group AB (publ) (LYGRD), Lappland Guldprospektering AB (publ) (LGOLD B), Lammhults Design Group AB (publ) (LAMM B), CodeMill AB (publ) (CDMIL), Invoicery Group AB (publ) (FRILAN)